to experience the full functionality of mail.com.
Enhanced by Google
Johnson & Johnson
February 04, 2016
Johnson & Johnson, ViaCyte testing possible diabetes cure
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to ...
January 26, 2016
Johnson & Johnson beats 4Q profit views despite lower sales
Johnson & Johnson posted a 28 percent jump in fourth-quarter profit, beating Wall Street expectations, as the sale of part ...
January 21, 2016
Applications for US unemployment aid rise to 6-month high
The number of people seeking unemployment benefits rose last week to the highest level since July, though applications ...
January 19, 2016
Johnson & Johnson to cut about 3,000 jobs in medical devices
Johnson & Johnson said Tuesday that it plans to cut about 3,000 jobs over the next two years as the health care conglomerate ...
January 19, 2016
High court rejects appeal over $63M judgment in Motrin case
The Supreme Court has rejected an appeal from the manufacturer of Children's Motrin over a $63 million judgment awarded to ...
January 11, 2016
High court won't hear appeal over $124M drug penalty
The Supreme Court won't hear an appeal from a Johnson & Johnson subsidiary assessed more than $124 million in penalties for ...
November 20, 2015
FDA approves Takeda drug for blood cancer multiple myeloma
The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.
November 16, 2015
Johnson & Johnson multiple myeloma drug wins accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple ...
November 03, 2015
J&J, ViiV: 2 injections every month or 2 could control HIV
Preliminary testing of two long-acting injectable drugs indicates it might be possible to keep HIV at bay indefinitely with ...
October 22, 2015
FDA warns of deadly liver damage with AbbVie hepatitis drugs
Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening ...
October 20, 2015
Why optimism about the US economy's strength has dimmed
Consumers, fueled by job growth, cheaper gas and higher home values, would drive the U.S. economy through a global slump.
October 19, 2015
Johnson & Johnson: Stelara fares well in Crohn's disease
Johnson & Johnson's immune disorder drug Stelara significantly reduced symptoms of the inflammatory bowel condition Crohn's ...
October 13, 2015
Johnson & Johnson posts mixed 3Q results, authorizes buyback
Johnson & Johnson, continuing a tough year of declining revenue, posted a 29 percent drop in third-quarter earnings as it was ...
October 09, 2015
Johnson & Johnson starts Ebola vaccine trial in Sierra Leone
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study ...
September 21, 2015
Biotech stocks fall on Clinton vow to fight 'price gouging'
Stocks of makers of biologic and "specialty" drugs plunged Monday after Democratic presidential frontrunner Hillary Clinton ...
September 17, 2015
Study: Type 2 diabetes pill Jardiance cuts risk of death
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making ...
August 27, 2015
Contact lens makers take fight over price law to court
Contact lens makers struggled Thursday to defend their pricing policies in a federal appeals case that could have ...